Adam Keeney
Corporate Officer/Principal at BIOGEN INC.
Net worth: 134 029 $ as of 2024-04-29
Profile
Adam Keeney is currently the Executive VP & Head-Corporate Development at Biogen, Inc. Prior to this, he worked as the President, Chief Executive Officer & Director at NodThera Ltd.
He completed his undergraduate degree at the University of Leeds and his doctorate at The University of Nottingham.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOGEN INC.
0.00% | 2024-04-30 | 662 ( 0.00% ) | 134 029 $ | 2024-04-29 |
Adam Keeney active positions
| Companies | Position | Start |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 2023-04-16 |
Former positions of Adam Keeney
| Companies | Position | End |
|---|---|---|
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Chief Executive Officer | - |
Training of Adam Keeney
| The University of Nottingham | Doctorate Degree |
| University of Leeds | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Adam Keeney
